Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
11/07/202406:30Alliance NewsAlliance NewsGET READY: Hays, Jet2, Severn Trent and Trustpilot at 0700 BST
11/07/202406:30Alliance NewsAlliance NewsAlliance News UK - start of day
11/07/202406:30UK RegulatoryBGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
11/07/202406:30UK RegulatoryTryg A/S – Q2 and H1 report 2024
11/07/202406:30UK RegulatoryBGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
11/07/202406:30UK RegulatorySampo plc’s share buybacks 10 July 2024
11/07/202406:30UK RegulatoryBGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
11/07/202406:30UK RegulatoryBGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
11/07/202406:19PR Newswire (US)Bitget Q2 Report Highlights $700M Capital Inflow and nearly 50% Rise in Traffic
11/07/202406:09PR Newswire (US)Freedomverse and the Tourism Authority of Thailand Partner to Elevate Thailand Travel Experience with the Freedom World Mobile App
11/07/202406:02PR Newswire (US)iQIYI Launches AI Chatbots for Popular Show Characters, Enhancing Interactive Content ExperienceNASDAQ:IQiQiyi Inc
11/07/202406:00UK RegulatoryNokia to publish second-quarter and half-year financial report on 18 July 2024BIT:1NOKIANokia Corp
11/07/202406:00UK RegulatoryNokia to publish second-quarter and half-year financial report on 18 July 2024TG:NOA3Nokia Corp
11/07/202406:00UK RegulatoryNokia to publish second-quarter and half-year financial report on 18 July 2024BIT:NOKIANokia Corp
11/07/202406:00UK RegulatoryIpsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class potentialTG:I7GIpsen SA
11/07/202406:00UK RegulatoryKitron: Q2 2024 - Robust profitability and positive outlook despite sector challengesLSE:0F0JKitron Asa
11/07/202406:00UK RegulatoryIpsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class potentialEU:IPNIpsen SA
11/07/202406:00UK RegulatoryIpsen et Foreseen Biotechnology annoncent la signature d’un accord exclusif de licence mondiale pour un conjugué anticorps-médicament doté d'un potentiel de première classeTG:I7GIpsen SA
11/07/202406:00UK RegulatoryIpsen et Foreseen Biotechnology annoncent la signature d’un accord exclusif de licence mondiale pour un conjugué anticorps-médicament doté d'un potentiel de première classeEU:IPNIpsen SA
11/07/202406:00UK RegulatoryStart of Day Message
11/07/202406:00UK RegulatoryNMD Pharma adds new capabilities with several senior recruits to support its growing business and pipeline
11/07/202406:00UK RegulatoryLinky : L'AI ChatBot le Plus Polyvalent au Monde
11/07/202406:00PR Newswire (US)Altair Names Minsait Channel Partner for the EMEA RegionNASDAQ:ALTRAltair Engineering Inc
11/07/202406:00UK RegulatoryPR Newswire - Start of Day
11/07/202406:00PR Newswire (US)FURNITURE CHINA 2024 Thrives with Enhanced Original Chinese Design and International Markets during 10-13 September in Pudong
11/07/202405:45Alliance NewsAlliance NewsGLOBAL BRIEFING: Stocks called up after Powell comments to Congress
11/07/202405:37PR Newswire (US)Bitget Q2 Report Highlights $700M Capital Inflow and nearly 50% Rise in Traffic
11/07/202405:24PR Newswire (US)Making it Easy to Find Veal for Your Meals
11/07/202405:19PR Newswire (US)iGaming Platform BC.GAME Signs $40 Million Deal to Become Principal Partner of Leicester City
11/07/202405:10PR Newswire (US)This is Nishan